I agree that this site is using cookies. You can find further informations here.
X
Natalie McGauran
41  results:
Search for persons X
?
1

A systematic comparison of different composite measures (DA..:

Janke, Kirsten ; Kiefer, Corinna ; McGauran, Natalie...
BMC Rheumatology.  6 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
2

Centralised Full Access to Clinical Study Data Can Support ..:

McGauran, Natalie ; Wieseler, Beate
Journal of European CME.  10 (2021)  1 - p. , 2021
Link: https://doi.org/10.1080/..
 
?
3

Results on patient-reported outcomes are underreported in s..:

Haag, Susanne ; Junge, Lisa ; Lotz, Fabian...
Journal of Patient-Reported Outcomes.  5 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
4

From publication bias to lost in information: why we need a..:

Wieseler, Beate ; McGauran, Natalie
BMJ Evidence-Based Medicine.  27 (2020)  2 - p. 74-76 , 2020
Link: https://doi.org/10.1136/..
 
?
5

New drugs: where did we go wrong and what can we do better?:

Wieseler, Beate ; McGauran, Natalie ; Kaiser, Thomas
BMJ: British Medical Journal.  366 (2019)  - p. 1-8 , 2019
Link: https://www.jstor.org/st..
 
?
6

Guideline appraisal with AGREE II: online survey of the pot..:

Hoffmann-Eßer, Wiebke ; Siering, Ulrich ; Neugebauer, Edmund A. M....
BMC Health Services Research.  18 (2018)  1 - p. , 2018
Link: https://doi.org/10.1186/..
 
?
7

Inconsistent conclusions on QoL outcomes from the same clin..:

Lange, Stefan ; Gaertner, Jan ; McGauran, Natalie..
Gastric Cancer.  19 (2015)  1 - p. 318-319 , 2015
Link: https://doi.org/10.1007/..
 
?
8

Information on new drugs at market entry: retrospective ana..:

Köhler, Michael ; Haag, Susanne ; Biester, Katharina...
BMJ: British Medical Journal.  350 (2015)  - p. , 2015
Link: https://www.jstor.org/st..
 
?
9

Impact of Inclusion of Industry Trial Results Registries as..:

Potthast, Regine ; Vervölgyi, Volker ; McGauran, Natalie...
PLoS ONE.  9 (2014)  4 - p. e92067 , 2014
Link: https://doi.org/10.1371/..
 
?
10

Response to Letter to the Editor on "Early benefit assessme..:

Hörn, Helmut ; Nink, Katrin ; McGauran, Natalie.
Health Policy.  118 (2014)  2 - p. 272 , 2014
Link: https://doi.org/10.1016/..
 
?
11

Early benefit assessment of new drugs in Germany – Results ..:

Hörn, Helmut ; Nink, Katrin ; McGauran, Natalie.
Health Policy.  116 (2014)  2-3 - p. 147-153 , 2014
Link: https://doi.org/10.1016/..
 
?
12

Patientenrelevante Endpunkte und Surrogate in der frühen Nu..:

Kvitkina, Tatjana ; ten Haaf, Anette ; Reken, Stefanie..
Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen.  108 (2014)  8-9 - p. 528-538 , 2014
Link: https://doi.org/10.1016/..
 
?
13

Completeness of Reporting of Patient-Relevant Clinical Tria..:

Wieseler, Beate ; Wolfram, Natalia ; McGauran, Natalie...
PLoS Medicine.  10 (2013)  10 - p. e1001526 , 2013
Link: https://doi.org/10.1371/..
 
?
14

Access to regulatory data from the European Medicines Agenc..:

Wieseler, Beate ; McGauran, Natalie ; Kerekes, Michaela F.
Systematic Reviews.  1 (2012)  1 - p. , 2012
Link: https://doi.org/10.1186/..
 
?
15

We need access to data on all clinical trials, not just som:

Wieseler, Beate ; McGauran, Natalie ; Kaiser, Thomas
BMJ: British Medical Journal.  345 (2012)  7885 - p. 29 ff. , 2012
Link: https://www.jstor.org/st..
 
1-15